PDCD1 and head and neck squamous cell carcinoma: Resistance to PD‐1 therapy is still a frequently observed clinical scenario in HNSCC and the presence of terminally exhausted T‐cells has been proposed to be a possible cause of resistance toward PD‐1 therapy [31].